Search research articles
Contact Us
Filters
Showing results (211-220 of 413) with videos related to
Page
of 42
Sort By:
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology
|
April 1, 1992
Novel steroid-based inhibitors of lung inflammation
I M Richards, S K Shields, R L Griffin, et al.
Antimicrobial Agents and Chemotherapy
|
September 25, 2013
Anidulafungin and micafungin MIC breakpoints are superior to that of caspofungin for identifying FKS mutant Candida glabrata strains and Echinocandin resistance
Ryan K Shields, M Hong Nguyen, Ellen G Press, et al.
Infectious Diseases and Therapy
|
May 31, 2024
Ceftazidime-Avibactam in the Treatment of Patients with Bacteremia or Nosocomial Pneumonia: A Systematic Review and Meta-analysis
Ryan K Shields, Juan P Horcajada, Shweta Kamat, et al.
Infectious Diseases and Therapy
|
August 28, 2024
Correction to: Ceftazidime‑Avibactam in the Treatment of Patients with Bacteremia or Nosocomial Pneumonia: A Systematic Review and Meta‑analysis
Ryan K Shields, Juan P Horcajada, Shweta Kamat, et al.
Antimicrobial Agents and Chemotherapy
|
March 21, 2012
The combination of doripenem and colistin is bactericidal and synergistic against colistin-resistant, carbapenemase-producing Klebsiella pneumoniae
Meredith G Jernigan, Ellen G Press, M Hong Nguyen, et al.
Journal of Magnetic Resonance Imaging : JMRI
|
March 1, 1992
Phantom limb pain induced in amputee by strong magnetic fields
W T Yuh, D J Fisher, R K Shields, et al.
Antimicrobial Agents and Chemotherapy
|
May 15, 2013
Caspofungin MICs correlate with treatment outcomes among patients with Candida glabrata invasive candidiasis and prior echinocandin exposure
Ryan K Shields, M Hong Nguyen, Ellen G Press, et al.
Antimicrobial Agents and Chemotherapy
|
February 23, 2017
Mutations in <i>bla</i><sub>KPC-3</sub> That Confer Ceftazidime-Avibactam Resistance Encode Novel KPC-3 Variants That Function as Extended-Spectrum β-Lactamases
Ghady Haidar, Cornelius J Clancy, Ryan K Shields, et al.
International Journal of Antimicrobial Agents
|
December 27, 2025
Clinical outcomes of metronidazole dosing strategies in obese patients with Bacteroides bloodstream infections
Sunish Shah, Rachel V Marini, Dayna McManus, et al.
Microbial Drug Resistance (Larchmont, N.Y.)
|
January 25, 2022
Mechanisms of Reduced Susceptibility to Cefiderocol Among Isolates from the CREDIBLE-CR and APEKS-NP Clinical Trials
Patrice Nordmann, Ryan K Shields, Yohei Doi, et al.
Page
of 42
Search research articles
Search
Showing results (211-220 of 413) with videos related to
Sort By:
Page
of 42
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology
|
April 1, 1992
Novel steroid-based inhibitors of lung inflammation
I M Richards, S K Shields, R L Griffin, et al.
Antimicrobial Agents and Chemotherapy
|
September 25, 2013
Anidulafungin and micafungin MIC breakpoints are superior to that of caspofungin for identifying FKS mutant Candida glabrata strains and Echinocandin resistance
Ryan K Shields, M Hong Nguyen, Ellen G Press, et al.
Infectious Diseases and Therapy
|
May 31, 2024
Ceftazidime-Avibactam in the Treatment of Patients with Bacteremia or Nosocomial Pneumonia: A Systematic Review and Meta-analysis
Ryan K Shields, Juan P Horcajada, Shweta Kamat, et al.
Infectious Diseases and Therapy
|
August 28, 2024
Correction to: Ceftazidime‑Avibactam in the Treatment of Patients with Bacteremia or Nosocomial Pneumonia: A Systematic Review and Meta‑analysis
Ryan K Shields, Juan P Horcajada, Shweta Kamat, et al.
Antimicrobial Agents and Chemotherapy
|
March 21, 2012
The combination of doripenem and colistin is bactericidal and synergistic against colistin-resistant, carbapenemase-producing Klebsiella pneumoniae
Meredith G Jernigan, Ellen G Press, M Hong Nguyen, et al.
Journal of Magnetic Resonance Imaging : JMRI
|
March 1, 1992
Phantom limb pain induced in amputee by strong magnetic fields
W T Yuh, D J Fisher, R K Shields, et al.
Antimicrobial Agents and Chemotherapy
|
May 15, 2013
Caspofungin MICs correlate with treatment outcomes among patients with Candida glabrata invasive candidiasis and prior echinocandin exposure
Ryan K Shields, M Hong Nguyen, Ellen G Press, et al.
Antimicrobial Agents and Chemotherapy
|
February 23, 2017
Mutations in <i>bla</i><sub>KPC-3</sub> That Confer Ceftazidime-Avibactam Resistance Encode Novel KPC-3 Variants That Function as Extended-Spectrum β-Lactamases
Ghady Haidar, Cornelius J Clancy, Ryan K Shields, et al.
International Journal of Antimicrobial Agents
|
December 27, 2025
Clinical outcomes of metronidazole dosing strategies in obese patients with Bacteroides bloodstream infections
Sunish Shah, Rachel V Marini, Dayna McManus, et al.
Microbial Drug Resistance (Larchmont, N.Y.)
|
January 25, 2022
Mechanisms of Reduced Susceptibility to Cefiderocol Among Isolates from the CREDIBLE-CR and APEKS-NP Clinical Trials
Patrice Nordmann, Ryan K Shields, Yohei Doi, et al.
Page
of 42